Physician profile
Antoine Naim
NPI 1801905583
$677.05
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $15.90 · 2021: $81.48 · 2022: $245 · 2023: $122 · 2024: $17.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.82 | 2019-2023 | |
| Minerva Surgical, INC | $72.54 | 2019 | |
| Pfizer INC. | $72.43 | 2022 | |
| Organon LLC | $61.43 | 2021-2022 | |
| Daiichi Sankyo INC. | $55.78 | 2021-2023 | Injectafer |
| Exeltis, USA INC. | $48.82 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $40.45 | 2019-2023 | |
| Olympus America INC. | $38.16 | 2019 | |
| Ethicon US, LLC | $34.08 | 2023 | Enseal |
| Shield Therapeutics INC | $33.72 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $15.36 | 2022-2023 | |
| Myovant Sciences INC. | $15.34 | 2021 | |
| Sage Therapeutics, LLC | $12.82 | 2021 | |
| Merck Sharp & Dohme LLC | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antoine Naim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.